Success Stories: A Chinese Resident Physician Secures NIW Approval in Just 8 Days, With Premium Processing Upgrade

Posted by wegreened on November 22, 2023 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“I was certainly delighted to hear this great news. Thank you to the whole team for all your help and expertise through this process.”

On August 8^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician in the Field of Biomedicine (Approval Notice).

General Field: Biomedicine

Position at the Time of Case Filing: Resident Physician

Country of Origin: China

Approval Notice Date: August 8^th, 2023

Processing Time: 8 days (Premium Processing Requested)

Case Summary:

Our NIW (National Interest Waiver) client from China is committed to advancing the development of new treatments for prevalent medical disorders like cancer, heart failure, and heart attacks by carrying out her study on disease mechanisms. After examining her research history, we concluded that the work she is doing to further her proposed venture is extremely important because it tackles two of the most serious medical issues facing modern society: cancer and cardiovascular disorders. Together, cancer and cardiovascular illnesses are the world's two greatest causes of death, accounting for around 27 million deaths annually.

Also, the six peer-reviewed journal articles (one of them first-authored, one co-first-authored) resulting from her study have been published in at least four highly regarded peer-reviewed journals. Besides, her peers have been influenced by her study. That is, according to Google Scholar, her works have been cited a total of 423 times, indicating that the biomedical community recognizes and values them highly.

Moreover, her study has received funding from the AHA, the NSF, the NIH, and the Burroughs Wellcome Foundation. This funding supports projects that promote national health and welfare through advancements in biomedical, cardiovascular, and cerebrovascular research. As a result, it is evident that her research promotes advances in the diagnosis, treatment, and prevention of disease, which have benefited the general public as well as the medical community.

All things considered, her research shows that she has already made headway in her broader goal of improving common disease prevention and treatment.

Once more, North America Immigration Law Group stood successful in convincing USCIS that our client has effectively used her abilities, greatly advancing her knowledge of cancer processes and therapies through her research. Thus, it was confirmed that she ought to carry out her studies in the US. After she applied for the premium processing service upgrade, her NIW case approval was granted in just 8 days. We wish her the best of luck in her future pursuits and are appreciative that she chose us to represent her NIW application.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%